Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36867660)

  • 21. Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism.
    Bullenkamp J; Raulf N; Ayaz B; Walczak H; Kulms D; Odell E; Thavaraj S; Tavassoli M
    Cell Death Dis; 2014 Oct; 5(10):e1489. PubMed ID: 25341043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase.
    Oh KJ; Kalinina A; Wang J; Nakayama K; Nakayama KI; Bagchi S
    J Virol; 2004 May; 78(10):5338-46. PubMed ID: 15113913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?
    Smith EM; Rubenstein LM; Ritchie JM; Lee JH; Haugen TH; Hamsikova E; Turek LP
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2087-96. PubMed ID: 18708401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
    Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
    Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells.
    Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
    Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.
    Smith EM; Pawlita M; Rubenstein LM; Haugen TH; Hamsikova E; Turek LP
    Int J Cancer; 2010 Jul; 127(1):111-7. PubMed ID: 19876924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
    Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
    PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.
    Sitz J; Blanchet SA; Gameiro SF; Biquand E; Morgan TM; Galloy M; Dessapt J; Lavoie EG; Blondeau A; Smith BC; Mymryk JS; Moody CA; Fradet-Turcotte A
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19552-19562. PubMed ID: 31501315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors.
    Wieking BG; Vermeer DW; Spanos WC; Lee KM; Vermeer P; Lee WT; Xu Y; Gabitzsch ES; Balcaitis S; Balint JP; Jones FR; Lee JH
    Cancer Gene Ther; 2012 Oct; 19(10):667-74. PubMed ID: 22918471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV
    Brand TM; Hartmann S; Bhola NE; Peyser ND; Li H; Zeng Y; Isaacson Wechsler E; Ranall MV; Bandyopadhyay S; Duvvuri U; LaVallee TM; Jordan RCK; Johnson DE; Grandis JR
    Clin Cancer Res; 2017 Jun; 23(12):3072-3083. PubMed ID: 27986750
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
    Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
    Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
    J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
    Brand TM; Hartmann S; Bhola NE; Li H; Zeng Y; O'Keefe RA; Ranall MV; Bandyopadhyay S; Soucheray M; Krogan NJ; Kemp C; Duvvuri U; LaVallee T; Johnson DE; Ozbun MA; Bauman JE; Grandis JR
    Cancer Res; 2018 May; 78(9):2383-2395. PubMed ID: 29440171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins.
    Rasheed K; Sveinbjørnsson B; Moens U
    Virol J; 2021 Jul; 18(1):139. PubMed ID: 34217322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer.
    Lee DW; Anderson ME; Wu S; Lee JH
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1316-23. PubMed ID: 19075129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. O-linked-N-acetylglucosamine transferase is associated with metastatic spread of human papillomavirus E6 and E7 oncoproteins to the lungs of mice.
    Kim SH; Kim YS; Choi MY; Kim M; Yang JH; Park HO; Jang IS; Moon SH; Kim HO; Song DH; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi JY; Choi WS
    Biochem Biophys Res Commun; 2017 Feb; 483(2):793-802. PubMed ID: 27845045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
    Shaikh MH; Idris A; Johnson NW; Fallaha S; Clarke DTW; Martin D; Morgan IM; Gabrielli B; McMillan NAJ
    Oral Oncol; 2018 Nov; 86():105-112. PubMed ID: 30409290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.